First Header Logo Second Header Logo

Connection

Tao Ma to Humans

This is a "connection" page, showing publications Tao Ma has written about Humans.
Connection Strength

0.494
  1. Zimmermann HR, Yang W, Kasica NP, Zhou X, Wang X, Beckelman BC, Lee J, Furdui CM, Keene CD, Ma T. Brain-specific repression of AMPKa1 alleviates pathophysiology in Alzheimer's model mice. J Clin Invest. 2020 07 01; 130(7):3511-3527.
    View in: PubMed
    Score: 0.042
  2. Wang X, Zimmermann HR, Lockhart SN, Craft S, Ma T. Decreased Levels of Blood AMPKa1 but not AMPKa2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study. J Alzheimers Dis. 2020; 76(1):217-224.
    View in: PubMed
    Score: 0.041
  3. Day SM, Ma T. Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease. Neurosci Bull. 2019 Oct; 35(5):934-936.
    View in: PubMed
    Score: 0.038
  4. Beckelman BC, Yang W, Kasica NP, Zimmermann HR, Zhou X, Keene CD, Ryazanov AG, Ma T. Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice. J Clin Invest. 2019 02 01; 129(2):820-833.
    View in: PubMed
    Score: 0.038
  5. Wang X, Zimmermann HR, Ma T. Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer's Disease. J Alzheimers Dis. 2019; 68(1):33-38.
    View in: PubMed
    Score: 0.038
  6. Cao C, Chai Y, Shou S, Wang J, Huang Y, Ma T. Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction. Int Immunopharmacol. 2018 Jan; 54:169-176.
    View in: PubMed
    Score: 0.035
  7. Beckelman BC, Day S, Zhou X, Donohue M, Gouras GK, Klann E, Keene CD, Ma T. Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease. J Alzheimers Dis. 2016 09 06; 54(2):669-78.
    View in: PubMed
    Score: 0.032
  8. Beckelman BC, Zhou X, Keene CD, Ma T. Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease. Neurodegener Dis. 2016; 16(1-2):39-43.
    View in: PubMed
    Score: 0.031
  9. Ma T, Chen Y, Vingtdeux V, Zhao H, Viollet B, Marambaud P, Klann E. Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid ß. J Neurosci. 2014 Sep 03; 34(36):12230-8.
    View in: PubMed
    Score: 0.028
  10. Ma T. GSK3 in Alzheimer's disease: mind the isoforms. J Alzheimers Dis. 2014; 39(4):707-10.
    View in: PubMed
    Score: 0.027
  11. Ma T, Trinh MA, Wexler AJ, Bourbon C, Gatti E, Pierre P, Cavener DR, Klann E. Suppression of eIF2a kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat Neurosci. 2013 Sep; 16(9):1299-305.
    View in: PubMed
    Score: 0.026
  12. Ma T, Klann E. Amyloid ß: linking synaptic plasticity failure to memory disruption in Alzheimer's disease. J Neurochem. 2012 Jan; 120 Suppl 1:140-8.
    View in: PubMed
    Score: 0.023
  13. Yang WZ, Guo JY, Li Y, An F, Zhang YQ, Ma T. [Transurethral resection of the prostate for urinary retention after seed implantation for prostate cancer: report of 2 cases]. Zhonghua Nan Ke Xue. 2011 Nov; 17(11):1011-3.
    View in: PubMed
    Score: 0.023
  14. Ma T, Hoeffer CA, Wong H, Massaad CA, Zhou P, Iadecola C, Murphy MP, Pautler RG, Klann E. Amyloid ß-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J Neurosci. 2011 Apr 13; 31(15):5589-95.
    View in: PubMed
    Score: 0.022
  15. Ma T, Hoeffer CA, Capetillo-Zarate E, Yu F, Wong H, Lin MT, Tampellini D, Klann E, Blitzer RD, Gouras GK. Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS One. 2010 Sep 20; 5(9).
    View in: PubMed
    Score: 0.021
  16. Zhou KY, Yang WZ, Cui ZY, Wei RJ, Zhao CL, Ma T, An F. [F4.8 visual miniature nephroscope for the diagnosis and treatment of hematospermia]. Zhonghua Nan Ke Xue. 2018 Jun; 24(6):525-528.
    View in: PubMed
    Score: 0.009
  17. Zhou X, Zhang J, Chen Y, Ma T, Wang Y, Wang J, Zhang Z. Aggravated cognitive and brain functional impairment in mild cognitive impairment patients with type 2 diabetes: a resting-state functional MRI study. J Alzheimers Dis. 2014; 41(3):925-35.
    View in: PubMed
    Score: 0.007
  18. Finan B, Ma T, Ottaway N, Müller TD, Habegger KM, Heppner KM, Kirchner H, Holland J, Hembree J, Raver C, Lockie SH, Smiley DL, Gelfanov V, Yang B, Hofmann S, Bruemmer D, Drucker DJ, Pfluger PT, Perez-Tilve D, Gidda J, Vignati L, Zhang L, Hauptman JB, Lau M, Brecheisen M, Uhles S, Riboulet W, Hainaut E, Sebokova E, Conde-Knape K, Konkar A, DiMarchi RD, Tschöp MH. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci Transl Med. 2013 Oct 30; 5(209):209ra151.
    View in: PubMed
    Score: 0.007
  19. Tampellini D, Rahman N, Gallo EF, Huang Z, Dumont M, Capetillo-Zarate E, Ma T, Zheng R, Lu B, Nanus DM, Lin MT, Gouras GK. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci. 2009 Aug 05; 29(31):9704-13.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.